Lenalidomide Impurity 2 CAS 2197420-75-8

Purity 97%+In StockPharmacopoeial Impurity Standards
CAS No.2197420-75-8
Molecular FormulaC13H15N3O4
Molecular Weight277.28 g/mol
CategoryPharmacopoeial Impurity Standards / EP Impurities
AvailabilityIn Stock

Chemical Structure

Lenalidomide Impurity 2 CAS 2197420-75-8 chemical structure

Description

This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.

CATO supplies Lenalidomide Impurity 2 (CAS 2197420-75-8), a pharmacopoeial impurity reference standard (molecular formula C13H15N3O4, MW 277.28 g/mol) used for the identification and quantification of trace impurities in APIs.

Based on its molecular formula C13H15N3O4, Lenalidomide Impurity 2 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 277.28 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).

As a certified reference material (CRM), Lenalidomide Impurity 2 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.

Physical & Chemical Properties

Molecular FormulaC13H15N3O4
Molecular Weight277.28 g/mol
AppearancePale yellow to yellow crystalline powder
Purity97%+
StorageStore at 2-8°C, protect from light, keep sealed and dry
Solubility (reference)Soluble in DMSO, DMF, methanol
StabilityMay oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening
Degree of Unsaturation (DBE)8.0
UV AbsorptionUV-absorbing
Structural FeaturesAromatic ring present
CAS Registry Year (est.)1998
Nitrogen Atoms3

Related Lenalidomide Standards

Recommended Standards

Why CATO?